Form 8 (DD) - Futura Medical
Alexander Duggan, Chief Executive Officer of Futura Medical PLC, has disclosed his holdings following a dealing on September 25, 2026. He currently owns or controls 17,500,000 relevant securities, representing 1.18% of the company's shares. No short positions or derivative holdings were disclosed. This disclosure is made in accordance with Rule 8 of the Takeover Code.
Select text to share a quote on X · sign in to keep highlights & notes in your FUM notes
KEY INFORMATION
| (a) Full name of discloser: | Alexander Duggan | ||
| (d) Status of person making the disclosure: e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree) | Chief Executive Officer | ||
| (e) Date dealing undertaken: | 25 September 2026 | ||
| 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE | |||
| Class of relevant security: | |||
| Interests | Short positions | ||
| Number | % | Number | % |
| (1) Relevant securities owned and/or controlled: | 17,500,000 | 1.18 | |
- Cash-settled derivatives:
- Stock-settled derivatives (including options) and agreements to purchase/sell:
| TOTAL: | 17,500,000 | 1.18 |
All interests and all short positions should be disclosed.
- Rights to subscribe for new securities (including directors’ and other employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
DEALINGS BY THE PERSON MAKING THE DISCLOSURE
The currency of all prices and other monetary amounts should be stated.
Purchases and sales
| Class of relevant security | Purchase/sale | Number of securities | Price per unit |
- Cash-settled derivative transactions
- Stock-settled derivative transactions (including options)
- Writing, selling, purchasing or varying
- Exercise
- Other dealings (including subscribing for new securities)
- OTHER INFORMATION
- Indemnity and other dealing arrangements
- Agreements, arrangements or understandings relating to options or derivatives
- Attachments
Are any Supplemental Forms attached?
| Supplemental Form 8 (Open Positions) | NO |
| Supplemental Form 8 (SBL) | NO |
| Date of disclosure: | 29 September 2026 |
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.